August 7, 2026
avatar-torie-bosch
First Opinion editor

Wednesday was a critical day for mRNA vaccine watchers for two reasons.

On Aug. 5, 2026, the Food and Drug Administration approved the first mRNA flu vaccine. Exactly a year prior, on Aug. 5, 2025, health secretary Robert F. Kennedy Jr. canceled a half-billion dollars’ worth of contracts for 22 mRNA research projects, arguing that the data did not support the work.

In a First Opinion essay, Jeff Coller, Bloomberg distinguished professor of RNA biology and therapeutics at Johns Hopkins University and a co-founder of the Alliance for mRNA Medicines, runs through the tremendous strides in mRNA research since Kennedy’s announcement. “A year ago, Kennedy made his claims to the country, and the truth has been sitting in plain sight ever since,” he writes.

Recommendation of the week: The Invitation-Only Zone,” by Robert Boynton, looks at a rather bizarre historical episode: North Korea’s kidnapping of Japanese citizens. Boynton speaks with some of the returned abductees, their families, and others while asking the most important question: What exactly was North Korea trying to accomplish?



Adobe

I’m a neurologist. I’ve delivered ALS diagnoses. Then I received one myself

“Continued research at every level of understanding ALS is essential,” writes Christopher Campos, a neurologist who has the disease.

By Christopher Campos


I was in my office when bullets hit the CDC. A year later, the agency remains under attack

Public health workers protect everyone from outbreaks. Now those same people need protection.

By Daniel Jernigan


AI won’t enhance physician autonomy. It will further diminish it

Who will be blamed for the missed diagnosis: the trillion-dollar AI company, or the physician whose name is on the chart?

By Frances Mei Hardin


Former NIH Director Anthony Fauci testifies before the Senate Homeland Security and Governmental Affairs Committee hearing on July 29, 2026 in Washington, D.C.
Kevin Dietsch/Getty Images

The U.S. needs a 9/11 Commission-style independent body to investigate Covid response

Instead of finding a scapegoat or specifically punishing Anthony Fauci, expert calls for 9/11 style commission focused on improved pandemic response.

By Ronald Nahass


Fauci doesn’t have the answers on Covid’s origins. China does

If the Senate is truly interested in Covid’s origins, it should focus on China, not on persecuting Anthony Fauci, expert writes.

By David J. Hunter


One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was

In 2025, RFK Jr. claimed data did not support research into mRNA vaccines. The past year shows he was wrong

By Jeff Coller


A single virus particle, or “virion,” of measles virus, seen through a thin-section transmission electron micrograph (TEM).
Cynthia S. Goldsmith, William Bellini/CDC

What my colleagues and I will look for as we assess U.S. measles elimination status

Measles cases are way up. There have been 34 outbreaks this year alone. What does this mean for elimination status?

By Noel T. Brewer


Something is missing from movies about medical aid in dying

Pedro Almodóvar’s 'The Room Next Door' may have helped New York legalize assisted suicide.

By Anna Magdalena Elsner and Vanessa Rampton


Tear down the wall between M.D. and D.O. education

The training pipeline for physicians still runs on two tracks: one for M.D.s, one for D.O.s. That needs to change.

By Abigail MacKenzie and Vijay Rajput


Adobe

I’m using not-FDA-approved software to manage my diabetes. I’ve never felt better

Rapid-fire improvements in medical software, often engineered by AI, are leaving FDA in the dust.

By Dana P. Goldman


How Josée became one of the 7.9% of Québécois who die by assisted suicide

This is Josée's story of assisted dying in Quebec, where 7.9% of all deaths are now through medical aid in dying, the highest rate in the world.

By Sai Rajagopal


We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine

Generative medical AI should not be treated as a separate ‘practitioner’ licensed like an individual clinician, experts write.

By Humayun Chaudhry and Christy Valentine Theard


Adobe

STAT+ | Stop asking if AI is good for medicine

Overgeneralizations about AI can slow down adoption of tools that work.

By Priya Abani


More around STAT

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.